These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8965654)

  • 1. The neurotoxin MPTP increases calbindin-D28k levels in mouse midbrain dopaminergic neurons.
    Ng MC; Iacopino AM; Quintero EM; Marches F; Sonsalla PK; Liang CL; Speciale SG; German DC
    Brain Res Mol Brain Res; 1996 Mar; 36(2):329-36. PubMed ID: 8965654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration.
    Liang CL; Sinton CM; Sonsalla PK; German DC
    Neurodegeneration; 1996 Dec; 5(4):313-8. PubMed ID: 9117542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vulnerability of midbrain dopaminergic neurons in calbindin-D28k-deficient mice: lack of evidence for a neuroprotective role of endogenous calbindin in MPTP-treated and weaver mice.
    Airaksinen MS; Thoenen H; Meyer M
    Eur J Neurosci; 1997 Jan; 9(1):120-7. PubMed ID: 9042576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midbrain dopaminergic neurons in the mouse: co-localization with Calbindin-D28K and calretinin.
    Liang CL; Sinton CM; German DC
    Neuroscience; 1996 Nov; 75(2):523-33. PubMed ID: 8931015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse.
    German DC; Nelson EL; Liang CL; Speciale SG; Sinton CM; Sonsalla PK
    Neurodegeneration; 1996 Dec; 5(4):299-312. PubMed ID: 9117541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dopamine transporter mRNA levels in midbrain regions containing calbindin.
    Sanghera MK; Manaye KF; Liang CL; Lacopino AM; Bannon MJ; German DC
    Neuroreport; 1994 Aug; 5(13):1641-4. PubMed ID: 7819538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells.
    German DC; Manaye KF; Sonsalla PK; Brooks BA
    Ann N Y Acad Sci; 1992 May; 648():42-62. PubMed ID: 1353337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to paraquat-induced degeneration.
    McCormack AL; Atienza JG; Langston JW; Di Monte DA
    Neuroscience; 2006 Aug; 141(2):929-937. PubMed ID: 16677770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine transporter mRNA levels are high in midbrain neurons vulnerable to MPTP.
    Sanghera MK; Manaye K; McMahon A; Sonsalla PK; German DC
    Neuroreport; 1997 Oct; 8(15):3327-31. PubMed ID: 9351666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sparing of the dopaminergic neurons containing calbindin-D28k and of the dopaminergic mesocortical projections in weaver mutant mice.
    Gaspar P; Ben Jelloun N; Febvret A
    Neuroscience; 1994 Jul; 61(2):293-305. PubMed ID: 7969910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calbindin-D28k in nerve cell nuclei.
    German DC; Ng MC; Liang CL; McMahon A; Iacopino AM
    Neuroscience; 1997 Dec; 81(3):735-43. PubMed ID: 9316025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroactive peptides exist in the midbrain dopaminergic neurons that contain calbindin-D28k.
    German DC; Liang CL
    Neuroreport; 1993 May; 4(5):491-4. PubMed ID: 8513124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calbindin-D28k-containing neurons in the human hypothalamus: relationship to dopaminergic neurons.
    Sanghera MK; Zamora JL; German DC
    Neurodegeneration; 1995 Dec; 4(4):375-81. PubMed ID: 8846230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased midbrain dopaminergic cell activity following 2'CH3-MPTP-induced dopaminergic cell loss: an in vitro electrophysiological study.
    Bernardini GL; Speciale SG; German DC
    Brain Res; 1990 Sep; 527(1):123-9. PubMed ID: 1980838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys.
    Lavoie B; Parent A
    Neuroreport; 1991 Oct; 2(10):601-4. PubMed ID: 1684519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular calcium ion response to glucose in beta-cells of calbindin-D28k nullmutant mice and in betaHC13 cells overexpressing calbindin-D28k.
    Parkash J; Chaudhry MA; Amer AS; Christakos S; Rhoten WB
    Endocrine; 2002 Aug; 18(3):221-9. PubMed ID: 12450313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUN11602, a novel aniline compound, mimics the neuroprotective mechanisms of basic fibroblast growth factor.
    Murayama N; Kadoshima T; Takemoto N; Kodama S; Toba T; Ogino R; Noshita T; Oka T; Ueno S; Kuroda M; Shimmyo Y; Morita Y; Inoue T
    ACS Chem Neurosci; 2013 Feb; 4(2):266-76. PubMed ID: 23421678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide.
    Cosi C; Marien M
    Brain Res; 1998 Oct; 809(1):58-67. PubMed ID: 9795136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calbindin-D28K-containing neurons in animal models of neurodegeneration: possible protection from excitotoxicity.
    Iacopino A; Christakos S; German D; Sonsalla PK; Altar CA
    Brain Res Mol Brain Res; 1992 Apr; 13(3):251-61. PubMed ID: 1317497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium buffering properties of calbindin D28k and parvalbumin in rat sensory neurones.
    Chard PS; Bleakman D; Christakos S; Fullmer CS; Miller RJ
    J Physiol; 1993 Dec; 472():341-57. PubMed ID: 8145149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.